BPC-157 & TB-500 Wolverine Stack research peptideBest Seller
Recovery

BPC-157 & TB-500 Wolverine Stack

BPC-157 + TB-500 recovery blend — the "Wolverine Stack." 40mg preloaded pen for accelerated muscle, ligament, and tendon recovery research.

Purity

99%+

CAS Number

Status

In Stock

Dispatch

Same-Day (before 2pm)

Select Size

£130.00

Research verification required. All orders are reviewed before dispatch. You will receive an email confirmation and a WhatsApp or phone call within 60 minutes to verify your research purpose.

Third-Party CoA Included Free Delivery Over £75 Research Use Only

About BPC-157 & TB-500 Wolverine Stack

The BPC-157/TB-500 blend, often called the "Wolverine Stack," combines two synthetic peptides designed to accelerate injury recovery. The Wolverine Stack promotes faster healing of muscles, ligaments, and tendons, reducing inflammation and potentially enhancing mobility. The results in trials have proven the intended use, however this item has not yet been certified for public use. Preloaded 40mg easy-to-use pen. Trials have shown the most effective use of BPC-157 is for the product to be injected near the injury site to target local healing in tendons or ligaments. Subjects commenced dosage at 2mg twice weekly and increased the dosage over a period of time until the desired results were reached. Researchers recommended cycling this stack for best results — periods of active use followed by rest periods to maintain the body's natural healing response.

Research Applications

Research Mechanism — BPC-157 & TB-500 Wolverine Stack

A simplified summary of what BPC-157 & TB-500 Wolverine Stack is studied for in research models. For laboratory in-vitro use only.

Sequence:BPC-157 (15 aa, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) + TB-500 (43 aa, Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-…-Ser)

Origin: Two-peptide research stack pairing BPC-157 (synthetic gastric-protective fragment) with TB-500 (synthetic Thymosin Beta-4 fragment). Each is supplied separately and not co-formulated.

  1. Molecular targets — combined

    Investigated as a research pairing because the two peptides are studied at largely non-overlapping targets, allowing combined exploration of growth-factor and cytoskeletal pathways in the same model.

    • BPC-157: VEGFR2 + FAK–paxillin focal-adhesion complex
    • TB-500: G-actin monomer + integrin-linked kinase (ILK)
    • Shared interest: endothelial nitric-oxide synthase (eNOS)
  2. Investigated pathways — combined

    Preclinical studies use the pairing to probe parallel effects on growth-factor signalling, cytoskeletal remodelling, and angiogenic responses in vitro.

    • Nitric-oxide release + actin polymerisation in parallel
    • VEGF-driven endothelial migration assays
    • Fibroblast proliferation and matrix-remodelling responses
  3. Preclinical research applications

    Used as a research stack in laboratory models exploring tissue-repair biology and cell-migration science. Each compound is supplied for in-vitro use only and is not approved for human use.

    • Tendon and ligament fibroblast research models
    • Wound-healing and cell-migration assays
    • Comparative studies against single-peptide controls

For research use only. BPC-157 & TB-500 Wolverine Stack is not approved as a medicine in the UK and is not intended for human or veterinary administration. See the compliance page for full terms.

Technical Specifications

Compound NameBPC-157 & TB-500 Wolverine Stack
CategoryRecovery
CAS Number
Molecular Weight
Molecular Formula
Sequence
Purity≥99%+ (HPLC)
FormLyophilised powder
Storage2-8°C refrigerated. Do not freeze.
ReconstitutionPre-mixed aqueous solution — no reconstitution required

Certificate of Analysis

Every order of BPC-157 & TB-500 Wolverine Stack includes a batch-specific CoA with HPLC chromatogram, mass spectrometry data, and laboratory accreditation details.

View Sample CoA

BPC-157 & TB-500 Wolverine Stack — Frequently Asked Questions

What is the Wolverine Stack?

The Wolverine Stack is a blend of BPC-157 (Body Protection Compound-157) and TB-500 (a synthetic analogue of thymosin beta-4). Together, they are designed to accelerate healing of muscles, ligaments, and tendons while reducing inflammation and enhancing mobility.

How was BPC-157 administered in trials?

Trials showed the most effective use was injection near the injury site to target local healing. Subjects started at 2mg twice weekly and gradually increased the dosage until desired results were reached. Researchers recommended cycling the stack — active use followed by rest periods.

Can the Wolverine Stack be combined with other peptides?

In research settings, the Wolverine Stack has been studied alongside other compounds. The GHK-Cu Glow Stack, which also contains BPC-157 and TB-500, combines these recovery peptides with copper peptide for additional regenerative benefits.

BPC-157 & TB-500 Wolverine Stack is supplied by Premio Peptides (BELL RED LIMITED) exclusively for in vitro laboratory research. It is not a licensed medicine, is not approved for human or veterinary use, and must not be administered to any living organism outside a formally approved research protocol. Purchasers assume full responsibility for compliance with applicable regulations.

Related Compounds